Last reviewed · How we verify
NCT06027333
Self-efficacy and Well-being of Patients With Fibrotic Interstitial Lung Disease
trial testing inpatient rehabilitation in Interstitial Lung Disease in 80 participants. Status unknown.
30 August 2024
Quick facts
| Lead sponsor | Berner Reha Zentrum AG |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 80 |
| Start date | 8 November 2023 |
| Primary completion | 30 August 2024 |
| Estimated completion | 30 August 2024 |
| Sites | 2 locations across Switzerland |
Drugs / interventions tested
- inpatient rehabilitation
Conditions studied
- Interstitial Lung Disease — all drugs for Interstitial Lung Disease →
- Fibrotic Lung Disease — all drugs for Fibrotic Lung Disease →
- Self Efficacy — all drugs for Self Efficacy →
- Self-management — all drugs for Self-management →
Sponsor
Berner Reha Zentrum AG
Who can join
18 and older, any sex, with Interstitial Lung Disease or Fibrotic Lung Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients with fibrotic insterstitial lung disease (ILD) participating in inpatient rehabilitation or in outpatient pulmonary care will be invited to participate in this observational study. Patients will fill out questionnaire regarding quality of life and symptoms at baseline and follow-up (at the end of rehabilitation or after the second outpatient ILD consultation). Additionally, clinical data obtained in clinical routine or for the IIP registry will be used for this project. The aim is to assess changes in self-efficacy and quality of life over time and to establish a control cohort for a later feasibility study on a educational and self-management intervention (currently in planning).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06027333
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of inpatient rehabilitation
Trials testing the same drug.
- NCT06307210 — Is Inpatient Rehabilitation Effective for Very Old Patients? · completed
Other recruiting trials for Interstitial Lung Disease
Currently open trials in the same condition.
- NCT07451977 — Effects of Oxygen Supplementation During the 6-Minute Walk Test in Chronic Respiratory Failure or Exertional Hypoxemia · NA · recruiting
- NCT07254338 — Exploration of Metabolome in Patients With Interstitial Lung Disease and Pulmonary Hypertension With or Without Specific · recruiting
- NCT07269262 — SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers · NA · recruiting
- NCT07179380 — Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension · Phase 3 · recruiting
- NCT07323732 — A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Diseas · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06027333 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Berner Reha Zentrum AG
- Last refreshed: 13 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06027333.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing